Global Health (BOM:543654) EPS (Basic): ₹20.71 (TTM As of Mar. 2026)


BOM:543654 Global Health Ltd BOM:543654
94 GF Score
Price ₹1,303.95
GF Value ₹1,470.53
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Global Health EPS (Basic)?

Global Health BOM:543654 +1.20% 94 EPS (Basic) is ₹20.71 as of Mar. 2026. GuruFocus rates BOM:543654 with a GF Score™ of 94/100 and a GF Value™ of ₹1,470.53 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Global Health's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ₹5.36. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹20.71.

Global Health's EPS (Diluted) for the three months ended in Mar. 2026 was ₹5.35. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹20.69.

Global Health's EPS without NRI for the three months ended in Mar. 2026 was ₹5.35. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 20.75.

During the past 12 months, Global Health's average EPS without NRIGrowth Rate was 7.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was 17.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was 58.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 7 years, Global Health's highest 3-Year average EPS without NRI Growth Rate was 128.50% per year. The lowest was 17.40% per year. And the median was 64.60% per year.

Global Health  (BOM:543654) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Global Health EPS (Basic) Related Terms

Global Health EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Global Health's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Global Health EPS (Basic) Chart

Global Health Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS (Basic)
Get a 7-Day Free Trial 7.75 12.58 17.80 17.92 20.71

Global Health Quarterly Data
Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.77 5.92 5.89 3.54 5.36
BOM:543654
94GF Score
Global Health Ltd BOM:543654
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Global Health EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Global Health's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(5564.6-0)/268.691
=20.71

Global Health's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(1439.88-0)/268.634
=5.36

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹20.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹20.71 mean?
Global Health (BOM:543654) has a EPS (Basic) of ₹20.71 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Global Health and its competitors.
Is Global Health's EPS (Basic) too high?
Global Health's current EPS (Basic) is ₹20.71. Overall, Global Health has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Global Health's EPS (Basic) compare to HCA and THC?
Global Health's EPS (Basic) of ₹20.71 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Healthcare Providers & Services company?
A good EPS (Basic) depends on the Healthcare Providers & Services industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Global Health and its competitors. Global Health's current EPS (Basic) is ₹20.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Global Health stock overvalued right now?
Based on GuruFocus' analysis, Global Health (BOM:543654) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,470.53, compared to a current price of ₹1,303.95 — trading 11.3% below its estimated fair value. The current EPS (Basic) is ₹20.71. Global Health's overall GF Score™ is 94/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Global Health (BOM:543654), the current EPS (Basic) is ₹20.71 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Global Health (BOM:543654) Overvalued in 2026?

Based on GuruFocus' analysis, Global Health stock appears to be undervalued. The current stock price of ₹1,303.95 is trading 11.3% below its estimated GF Value™ of ₹1,470.53. GuruFocus considers Global Health to be Modestly Undervalued.

Key valuation signals for BOM:543654:

  • EPS (Basic): ₹20.71
  • GF Value™: ₹1,470.53 vs. price of ₹1,303.95 (11.3% below fair value)
  • GF Score™: 94/100 with 1 warning sign

No single metric tells the full story. See the BOM:543654 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Global Health Business Description

Other Exchanges MEDANTA:India
Address Medanta - The Medicity, Sector-38, Gurugram, HR, IND, 122001
Global Health Ltd operates as a private multi-specialty tertiary care provider operating in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. Under the Medanta brand, it has a network of hospitals in operation (Gurugram, Indore, Ranchi, and Lucknow), a hospital that is under construction with an operational outpatient facility (Patna), and a hospital (Noida) planned for development. The Group operates Healthcare services as a single business segment in India, constituting a single geographical segment.
94GF Score

Get the complete analysis for BOM:543654

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,303.95
Price
₹1,470.53
GF Value